TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 1 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 100 | -96.4% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 2,800 | -81.5% | 0.00% | -100.0% |
| Q4 2017 | $41,000 | -70.9% | 15,148 | -79.4% | 0.00% | -80.0% |
| Q3 2017 | $141,000 | +65.9% | 73,418 | +45.4% | 0.01% | +66.7% |
| Q2 2017 | $85,000 | -59.7% | 50,500 | -56.5% | 0.00% | -66.7% |
| Q1 2017 | $211,000 | +1306.7% | 116,100 | +387.8% | 0.01% | – |
| Q4 2016 | $15,000 | +114.3% | 23,800 | -17.5% | 0.00% | – |
| Q3 2016 | $7,000 | -87.7% | 28,850 | -55.4% | 0.00% | -100.0% |
| Q2 2016 | $57,000 | -78.0% | 64,623 | -28.2% | 0.00% | -82.4% |
| Q1 2016 | $259,000 | +4.0% | 90,064 | -19.2% | 0.02% | +21.4% |
| Q4 2015 | $249,000 | – | 111,506 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 317,900 | $11,647,000 | 4.28% |
| Opaleye Management Inc. | 175,000 | $6,412,000 | 2.98% |
| Graticule Asia Macro Advisors LLC | 413,200 | $15,139,000 | 2.02% |
| BB BIOTECH AG | 1,477,114 | $54,121,000 | 1.61% |
| Iguana Healthcare Management, LLC | 75,000 | $2,748,000 | 1.16% |
| Granite Point Capital Management, L.P. | 79,250 | $2,904,000 | 1.06% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 458,202 | $16,788,000 | 0.89% |
| Ghost Tree Capital, LLC | 130,000 | $4,764,000 | 0.86% |
| SECTORAL ASSET MANAGEMENT INC | 605,393 | $22,182,000 | 0.84% |
| HealthCor Management, L.P. | 467,200 | $17,118,000 | 0.82% |